Research
Publications, Grants & Reviewing Activity
50 peer-reviewed publications spanning medical statistics, clinical trial methodology, AI for health, and precision oncology. Active reviewer for major funding bodies and leading journals. Over £6M in research funding as principal and co-investigator.
Selected publications — clinical trials & biostatistics
2016
An optimal stratified Simon two-stage design. D. Parashar et al.
Pharmaceutical Statistics 15 (2016) 333–340
2015
Type I error control in biomarker-stratified clinical trials. D. Parashar et al.
Trials 2015, 16(Suppl 2):O84
2019
On the need to adjust for multiplicity in confirmatory clinical trials with master protocols.
N. Stallard, D. Parashar et al.
Annals of Oncology 2019
2022
Efficiency of a randomized confirmatory basket trial design constrained to control
the false positive rate by indication. L. He, D. Parashar et al.
Statistical Methods in Medical Research 2022; 31(7): 1207–1223
2024
Immortal Time Bias: Zeroing in on time-zero. D. Parashar and J. Wang.
PSI SIG on Real-World Data (peer-reviewed), 2024
2013
The diagnostic value of white cell count, C-reactive protein and bilirubin in
acute appendicitis and its complications. I. Panagiotopoulou, D. Parashar et al.
Annals of the Royal College of Surgeons 95 (2013) 215–221
2017
Mammographic image quality in relation to positioning of the breast: A multicentre
international evaluation. K. Taylor, D. Parashar et al.
Radiography 2017; 23: 343–349 — Editors' Choice Award; criteria adopted in European breast cancer screening guidelines
2016
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial.
T.J. Johnston, D. Parashar et al.
European Urology 2016, 71: 381–388
2015
The UK experience of a treatment strategy for paediatric metastatic medulloblastoma
(Milan Strategy). S. Vivekanandan, D. Parashar et al.
Pediatric Blood & Cancer 62 (2015) 2132–2139
Selected publications — health AI & precision medicine
2025
Personalised Uncertainty Quantification in Artificial Intelligence.
T. Chakraborti, D. Parashar et al.
Nature Machine Intelligence 2025; 7: 522–530 — Turing–Roche partnership leadership
2026
Generating crossmodal gene expression from cancer histopathology improves multimodal
AI predictions. S. Dey, D. Parashar et al.
Nature Communications 17, Article 259 (2026) — Turing–Roche partnership leadership
2025
Generalized Evolutionary Classifier for Evolutionary Guided Precision Medicine.
M.D. McCoy, D. Parashar et al.
JCO Precision Oncology 2025: 9:e2300714 — Project co-lead
2023
Unlocking multidimensional cancer therapeutics using geometric data science.
D. Parashar.
Scientific Reports (Nature) 2023; 13: 8255 — Solo-authored
2021
Do Support Vector Machines play a role in stratifying patient population based on
cancer biomarkers? B. Lanza and D. Parashar.
Archives of Proteomics & Bioinformatics 2021; 2: 20–38
2016
Detection of colorectal dysplasia using fluorescently labelled lectins.
J.C-H. Kuo, D. Parashar et al.
Nature Scientific Reports 2016; 6:24231
Bold entries are particularly significant. Full list available on request.
Manuscripts under review
2026
Towards Multimodal Artificial Intelligence Assurance. T. Chakraborti, C. Burr,
D. Parashar et al. Communications in AI & Computing (under review).
Turing–Roche partnership leadership.
2026
A Proof-of-Concept Clinical Trial Design for Evolutionary Guided Precision Medicine
for Cancer. D. Parashar et al. medRxiv 2025; doi:10.1101/2025.05.23.25328210.
Submitted to Scientific Reports. Project co-lead.
Research funding (select)
Over £6M in competitive research funding as PI and co-investigator, spanning
MRC, NIHR, Wellcome Trust, Royal Society, Cancer Research UK, and European Research Council.
2024
Turing–Roche Strategic Partnership (Deputy Lead). F. Hoffmann-La Roche Ltd /
The Alan Turing Institute. £5 million partnership
2020
MRC iCASE Studentship renewal — AstraZeneca co-sponsor (PI at Warwick).
MRC, £90,000
2020
Statistical Lead, NIHR i4i National Grant.
NIHR i4i, £975,000
2019
MRC iCASE Studentship — Roche co-sponsor (PI at Warwick).
MRC, £108,000
2019
Royal Society International Exchanges Award — UK / Georgetown University USA.
The Royal Society, £12,000
Expert Panels
US National Science Foundation · NIHR Health Technology Assessment Programme · MRC Hubs for Trials Methodology Research · MRC AI for Biomedical & Health Research Panel · MRC Clinical Academic Research Partnerships Panel · UKRI AI Innovation to Accelerate Health Research Panel · Cancer Research UK · Yorkshire Cancer Research · European Research Agency Personalised Medicine Review Panel.